https://www.selleckchem.com/pr....oducts/pyrrolidinedi
5%) (n = 56) 60% in the SMS arm and 30.6% in the control arm had lowered their HbA1c level (P = 0.03) in the intent-to-treat analysis but not in the per-protocol analysis (P = 0.5. Patients in the SMS arm reported high satisfaction with the intervention. While there is a trend to lower HbA1c in the intervention group, no firm conclusions can yet be drawn. Further studies are needed to address methodological issues as we believe these interventions can support behavior change among adolescents with p
Me gusta
Comentario
Compartir
